欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2006, Vol. 11 ›› Issue (9): 1035-1038.

• 研究原著 • 上一篇    下一篇

卡维地洛对映体的抗心肌细胞凋亡作用

刘晓颖, 杨敏, 林秋雄, 余细勇, 单志新, 郑猛, 林曙光   

  1. 广东省人民医院医学研究中心, 广东省心血管病研究所, 广州 510080, 广东
  • 收稿日期:2006-07-20 修回日期:2006-08-29 出版日期:2006-09-26 发布日期:2020-11-05
  • 通讯作者: 余细勇,男, 博士, 教授, 博士生导师, 研究方向:临床药理学和分子心血管病学。Tel:020-83827812-51155 E-mail:yuxycn@hotmail.com
  • 作者简介:刘晓颖, 女, 硕士, 实习研究员, 研究方向:心血管药理。Tel:020-83827812-51150 E-mail:daisylee13fri@yahoo.com.cn
  • 基金资助:
    广东省自然科学基金团队项目(No015015);广东省科技厅攻关项目(No2004B30601009);2003 广东省社会发展领域科技计划项目;广东省人民医院院内启动基金项目(NoY02084)

Anti-apoptotic effects of carvedilol enantiomers in cardiac myocytes

LIU Xiao-ying, YANG Min, LIN Qiu-xiong, YU Xi-yong, SHAN Zhi-xin, ZHENG Meng, LIN Shuguang   

  1. Resarch Center of Medical Science , Guangdong Provincial Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangzhou 510080 , Guangdong, China
  • Received:2006-07-20 Revised:2006-08-29 Online:2006-09-26 Published:2020-11-05

摘要: 目的 研究卡维地洛(carvedilol) R (+) 和S(-) 型对映体对心肌细胞的凋亡保护作用。方法 异丙肾上腺素(ISO) 2 mmol·L-1 作用12 h 以诱导H9C2-1 心肌细胞凋亡, Hoechst 33258 染色法定性凋亡细胞, Annexin Ⅴ-FITC/ PI 双染标记细胞后以流式细胞仪测定标记率以定量凋亡率。处理组同时加入R (+) 或S (-) carvedilol, 分2 和10 μmol·L-1两个浓度组。并分别测定10 μmol·L-1 R (+) 或S (-)carvedilol 单一作用的细胞凋亡率。结果 2 mmol·L-1 ISO 作用12 h 后H9C2-1 细胞大量凋亡(p<0.01);R (+) 或S (-) carvedilol +ISO 组细胞凋亡率显著低于ISO 组(p<0.05);与低剂量组间比较, R (+) carvedilol +ISO 细胞晚期凋亡率和总凋亡率低于S(-) carvedilol+ISO, 差异有显著性意义(p<0.05);高剂量S (-) carvedilol 组细胞凋亡率略有升高, 但显著低于S (-) Carv 10μmol·L-1 +ISO 组(p<0.05) 。结论 ISO 可诱导-H9C2-1 心肌细胞凋亡, 低剂量R (+) 或S (-) carvedilol 对此均有明显的抑制作用, 并且R (+) 和S (-) 型carvedilol 的抗心肌细胞凋亡效应间存在一定的立体选择性差异, R (+) carvedilol 显示出更具潜力。

关键词: 卡维地洛, 对映体, 抗凋亡, 心肌细胞

Abstract: AIM: To investigate the anti-apoptotic effects of R (+) and S (-) enantiomers of carvedilol in cardiac myocytes.METHODS: H9C2-1 cardiac myocytes were induced to apoptosis by isopropylarterenol(ISO) for 12 h, R (+) carvedilol or S (-) carvedilol was added as the treatment with 2 μmol·L-1 or 10μmol·L-1 dose.Apoptotic cells were identified by Hoechst 33258, and for the determination of apoptosis ratio,Annexin Ⅴ-FITC/ PI double-staining assay was applied with the flow cytometer.The apoptotic effect of 10 μmol R (+) (carvedilol) or S (-) carvedilol alone on cell was also measured.RESULTS: 2 mmol·L-1 ISO induced a apoptosis in a great quantity of H9C2-1 cells (p<0.01) , and R (+) (carvedilol) or S (-) carvedilol could decreased the apoptotic ratio markedly(p<0.01).The late stage and total apoptotic ratios of 2 μmol·L-1 R(+) carvedilol +ISO were lower than those of 2 μmol S (-) carvedilol +ISO group(p<0.05) ,but there is no significant difference between 10 μmol·L-1 group.The apoptotic ratio of 10 μmol·L-1 S(-) carvedilol itself was a little higher than that of control but was much lower than that of ISO groups (p<0.05).CONCLUSION: Both R (+) (carvedilol) and S (-) carvedilol can effectively inhibit the apoptosis of H9C2-1 cardiac myoctytes induced by ISO, and there is stereoselective difference in it's anti-apoptotic activity on cardiac myocytes between these two enantiomers.R(+) carvedilol is more potential to antagonize the cell apoptosis.

Key words: carvedilol, enantiomers, anti-apoptosis, cardiac myocytes

中图分类号: